Neuroprotective Transcription Factors in Animal Models of Parkinson Disease

A number of transcription factors, including En1/2, Foxa1/2, Lmx1a/b, Nurr1, Otx2, and Pitx3, with key roles in midbrain dopaminergic (mDA) neuron development, also regulate adult mDA neuron survival and physiology. Mouse models with targeted disruption of some of these genes display several feature...

Full description

Saved in:
Bibliographic Details
Main Authors: François-Xavier Blaudin de Thé, Hocine Rekaik, Alain Prochiantz, Julia Fuchs, Rajiv L. Joshi
Format: Article
Language:English
Published: Wiley 2016-01-01
Series:Neural Plasticity
Online Access:http://dx.doi.org/10.1155/2016/6097107
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563242829873152
author François-Xavier Blaudin de Thé
Hocine Rekaik
Alain Prochiantz
Julia Fuchs
Rajiv L. Joshi
author_facet François-Xavier Blaudin de Thé
Hocine Rekaik
Alain Prochiantz
Julia Fuchs
Rajiv L. Joshi
author_sort François-Xavier Blaudin de Thé
collection DOAJ
description A number of transcription factors, including En1/2, Foxa1/2, Lmx1a/b, Nurr1, Otx2, and Pitx3, with key roles in midbrain dopaminergic (mDA) neuron development, also regulate adult mDA neuron survival and physiology. Mouse models with targeted disruption of some of these genes display several features reminiscent of Parkinson disease (PD), in particular the selective and progressive loss of mDA neurons in the substantia nigra pars compacta (SNpc). The characterization of these animal models has provided valuable insights into various mechanisms of PD pathogenesis. Therefore, the dissection of the mechanisms and survival signalling pathways engaged by these transcription factors to protect mDA neuron from degeneration can suggest novel therapeutic strategies. The work on En1/2-mediated neuroprotection also highlights the potential of protein transduction technology for neuroprotective approaches in PD.
format Article
id doaj-art-bf32e04f1e9741b1acdcbdfeea52f41b
institution Kabale University
issn 2090-5904
1687-5443
language English
publishDate 2016-01-01
publisher Wiley
record_format Article
series Neural Plasticity
spelling doaj-art-bf32e04f1e9741b1acdcbdfeea52f41b2025-02-03T01:20:41ZengWileyNeural Plasticity2090-59041687-54432016-01-01201610.1155/2016/60971076097107Neuroprotective Transcription Factors in Animal Models of Parkinson DiseaseFrançois-Xavier Blaudin de Thé0Hocine Rekaik1Alain Prochiantz2Julia Fuchs3Rajiv L. Joshi4Center for Interdisciplinary Research in Biology (CIRB), Labex Memolife, CNRS UMR 7241, INSERM U1050, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, FranceCenter for Interdisciplinary Research in Biology (CIRB), Labex Memolife, CNRS UMR 7241, INSERM U1050, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, FranceCenter for Interdisciplinary Research in Biology (CIRB), Labex Memolife, CNRS UMR 7241, INSERM U1050, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, FranceCenter for Interdisciplinary Research in Biology (CIRB), Labex Memolife, CNRS UMR 7241, INSERM U1050, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, FranceCenter for Interdisciplinary Research in Biology (CIRB), Labex Memolife, CNRS UMR 7241, INSERM U1050, Collège de France, 11 place Marcelin Berthelot, 75231 Paris Cedex 05, FranceA number of transcription factors, including En1/2, Foxa1/2, Lmx1a/b, Nurr1, Otx2, and Pitx3, with key roles in midbrain dopaminergic (mDA) neuron development, also regulate adult mDA neuron survival and physiology. Mouse models with targeted disruption of some of these genes display several features reminiscent of Parkinson disease (PD), in particular the selective and progressive loss of mDA neurons in the substantia nigra pars compacta (SNpc). The characterization of these animal models has provided valuable insights into various mechanisms of PD pathogenesis. Therefore, the dissection of the mechanisms and survival signalling pathways engaged by these transcription factors to protect mDA neuron from degeneration can suggest novel therapeutic strategies. The work on En1/2-mediated neuroprotection also highlights the potential of protein transduction technology for neuroprotective approaches in PD.http://dx.doi.org/10.1155/2016/6097107
spellingShingle François-Xavier Blaudin de Thé
Hocine Rekaik
Alain Prochiantz
Julia Fuchs
Rajiv L. Joshi
Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
Neural Plasticity
title Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
title_full Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
title_fullStr Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
title_full_unstemmed Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
title_short Neuroprotective Transcription Factors in Animal Models of Parkinson Disease
title_sort neuroprotective transcription factors in animal models of parkinson disease
url http://dx.doi.org/10.1155/2016/6097107
work_keys_str_mv AT francoisxavierblaudindethe neuroprotectivetranscriptionfactorsinanimalmodelsofparkinsondisease
AT hocinerekaik neuroprotectivetranscriptionfactorsinanimalmodelsofparkinsondisease
AT alainprochiantz neuroprotectivetranscriptionfactorsinanimalmodelsofparkinsondisease
AT juliafuchs neuroprotectivetranscriptionfactorsinanimalmodelsofparkinsondisease
AT rajivljoshi neuroprotectivetranscriptionfactorsinanimalmodelsofparkinsondisease